Seeking Alpha

Pfizer (PFE) says the FDA has approved the expansion of the it's pneumococcal conjugate vaccine,...

Pfizer (PFE) says the FDA has approved the expansion of the it's pneumococcal conjugate vaccine, Prevnar 13, for use in older children and adolescents aged 6 years through 17 years for active immunization for the prevention of invasive disease caused by 13 distinct Streptococcus pneumoniae serotypes contained in the vaccine.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs